Eye Tumors View Full Text


Ontology type: schema:Chapter     


Chapter Info

DATE

2011-02-15

AUTHORS

John E. Munzenrider

ABSTRACT

The question of re-irradiating the eye after ocular radiation is rarely raised, since the eye is irradiated infrequently as a primary target. Rather, significant efforts are made to minimize the dose received incidentally by the eye during treatment of tumors of the orbit or peri-orbital areas, or of other head and neck or central nervous system sites. CT-based 3D treatment planning is essential for treating these sites, and the eye itself, since availability of archived dosimetry data regarding previously administered irradiation is invaluable when considering re-irradiation of the eye, or of new or recurrent tumors involving the orbit or other adjacent sites. This chapter will discuss the need for radiation oncologists to be aware of the differing threshold doses for complications involving various parts of the eye, specifically the lens, optic nerve, macula, and retina, as well as the tolerance of the lacrimal gland and the tear-producing cells in the eyelids. Recommendations are provided for determining the advisability of attempting re-irradiation of the eye after primary treatment with low, intermediate, or high doses. Advantages of focused radiation therapy techniques, specifically external beam proton therapy and episcleral radionuclide plaque brachytherapy for primary treatment or for re-irradiation of discrete ocular tumors are discussed. Finally, results of two retrospective studies of proton beam re-irradiation of ocular melanomas are described. More... »

PAGES

95-99

Book

TITLE

Re-irradiation: New Frontiers

ISBN

978-3-642-12467-9
978-3-642-12468-6

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/174_2010_107

DOI

http://dx.doi.org/10.1007/174_2010_107

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1048020567


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1113", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Ophthalmology and Optometry", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Department of Radiation Oncology, Cox 802, Massachusetts General Hospital, 02114, Boston, MA, USA", 
          "id": "http://www.grid.ac/institutes/grid.214458.e", 
          "name": [
            "Department of Radiation Oncology, Cox 802, Massachusetts General Hospital, 02114, Boston, MA, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Munzenrider", 
        "givenName": "John E.", 
        "id": "sg:person.0637022555.52", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0637022555.52"
        ], 
        "type": "Person"
      }
    ], 
    "datePublished": "2011-02-15", 
    "datePublishedReg": "2011-02-15", 
    "description": "The question of re-irradiating the eye after ocular radiation is rarely raised, since the eye is irradiated infrequently as a primary target. Rather, significant efforts are made to minimize the dose received incidentally by the eye during treatment of tumors of the orbit or peri-orbital areas, or of other head and neck or central nervous system sites. CT-based 3D treatment planning is essential for treating these sites, and the eye itself, since availability of archived dosimetry data regarding previously administered irradiation is invaluable when considering re-irradiation of the eye, or of new or recurrent tumors involving the orbit or other adjacent sites. This chapter will discuss the need for radiation oncologists to be aware of the differing threshold doses for complications involving various parts of the eye, specifically the lens, optic nerve, macula, and retina, as well as the tolerance of the lacrimal gland and the tear-producing cells in the eyelids. Recommendations are provided for determining the advisability of attempting re-irradiation of the eye after primary treatment with low, intermediate, or high doses. Advantages of focused radiation therapy techniques, specifically external beam proton therapy and episcleral radionuclide plaque brachytherapy for primary treatment or for re-irradiation of discrete ocular tumors are discussed. Finally, results of two retrospective studies of proton beam re-irradiation of ocular melanomas are described.", 
    "editor": [
      {
        "familyName": "Nieder", 
        "givenName": "Carsten", 
        "type": "Person"
      }, 
      {
        "familyName": "Langendijk", 
        "givenName": "Johannes A.", 
        "type": "Person"
      }
    ], 
    "genre": "chapter", 
    "id": "sg:pub.10.1007/174_2010_107", 
    "isAccessibleForFree": false, 
    "isPartOf": {
      "isbn": [
        "978-3-642-12467-9", 
        "978-3-642-12468-6"
      ], 
      "name": "Re-irradiation: New Frontiers", 
      "type": "Book"
    }, 
    "keywords": [
      "primary treatment", 
      "external beam proton therapy", 
      "central nervous system sites", 
      "nervous system sites", 
      "peri-orbital area", 
      "radiation therapy techniques", 
      "treatment of tumors", 
      "ocular radiation", 
      "recurrent tumors", 
      "optic nerve", 
      "plaque brachytherapy", 
      "retrospective study", 
      "ocular melanoma", 
      "lacrimal gland", 
      "ocular tumors", 
      "threshold doses", 
      "high doses", 
      "radiation oncologists", 
      "eye tumors", 
      "tumors", 
      "treatment planning", 
      "therapy techniques", 
      "eyes", 
      "system sites", 
      "treatment", 
      "proton therapy", 
      "primary target", 
      "doses", 
      "dosimetry data", 
      "complications", 
      "nerve", 
      "macula", 
      "oncologists", 
      "therapy", 
      "melanoma", 
      "retina", 
      "brachytherapy", 
      "neck", 
      "dose", 
      "eyelid", 
      "CT", 
      "gland", 
      "cells", 
      "head", 
      "sites", 
      "target", 
      "recommendations", 
      "study", 
      "advisability", 
      "tolerance", 
      "need", 
      "data", 
      "adjacent sites", 
      "significant efforts", 
      "irradiation", 
      "area", 
      "results", 
      "lens", 
      "availability", 
      "efforts", 
      "part", 
      "radiation", 
      "planning", 
      "questions", 
      "technique", 
      "chapter", 
      "advantages", 
      "orbit", 
      "proton beam", 
      "beam"
    ], 
    "name": "Eye Tumors", 
    "pagination": "95-99", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1048020567"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/174_2010_107"
        ]
      }
    ], 
    "publisher": {
      "name": "Springer Nature", 
      "type": "Organisation"
    }, 
    "sameAs": [
      "https://doi.org/10.1007/174_2010_107", 
      "https://app.dimensions.ai/details/publication/pub.1048020567"
    ], 
    "sdDataset": "chapters", 
    "sdDatePublished": "2022-12-01T06:47", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20221201/entities/gbq_results/chapter/chapter_146.jsonl", 
    "type": "Chapter", 
    "url": "https://doi.org/10.1007/174_2010_107"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/174_2010_107'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/174_2010_107'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/174_2010_107'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/174_2010_107'


 

This table displays all metadata directly associated to this object as RDF triples.

134 TRIPLES      22 PREDICATES      93 URIs      86 LITERALS      7 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/174_2010_107 schema:about anzsrc-for:11
2 anzsrc-for:1113
3 schema:author Ned9ebb4a63a54eab88d48b94ebbc7dc0
4 schema:datePublished 2011-02-15
5 schema:datePublishedReg 2011-02-15
6 schema:description The question of re-irradiating the eye after ocular radiation is rarely raised, since the eye is irradiated infrequently as a primary target. Rather, significant efforts are made to minimize the dose received incidentally by the eye during treatment of tumors of the orbit or peri-orbital areas, or of other head and neck or central nervous system sites. CT-based 3D treatment planning is essential for treating these sites, and the eye itself, since availability of archived dosimetry data regarding previously administered irradiation is invaluable when considering re-irradiation of the eye, or of new or recurrent tumors involving the orbit or other adjacent sites. This chapter will discuss the need for radiation oncologists to be aware of the differing threshold doses for complications involving various parts of the eye, specifically the lens, optic nerve, macula, and retina, as well as the tolerance of the lacrimal gland and the tear-producing cells in the eyelids. Recommendations are provided for determining the advisability of attempting re-irradiation of the eye after primary treatment with low, intermediate, or high doses. Advantages of focused radiation therapy techniques, specifically external beam proton therapy and episcleral radionuclide plaque brachytherapy for primary treatment or for re-irradiation of discrete ocular tumors are discussed. Finally, results of two retrospective studies of proton beam re-irradiation of ocular melanomas are described.
7 schema:editor Nae3a8d5af47f4b36bdcdd3a91304d20b
8 schema:genre chapter
9 schema:isAccessibleForFree false
10 schema:isPartOf N59a14d89d2cd42319be942bb5e8c9cd0
11 schema:keywords CT
12 adjacent sites
13 advantages
14 advisability
15 area
16 availability
17 beam
18 brachytherapy
19 cells
20 central nervous system sites
21 chapter
22 complications
23 data
24 dose
25 doses
26 dosimetry data
27 efforts
28 external beam proton therapy
29 eye tumors
30 eyelid
31 eyes
32 gland
33 head
34 high doses
35 irradiation
36 lacrimal gland
37 lens
38 macula
39 melanoma
40 neck
41 need
42 nerve
43 nervous system sites
44 ocular melanoma
45 ocular radiation
46 ocular tumors
47 oncologists
48 optic nerve
49 orbit
50 part
51 peri-orbital area
52 planning
53 plaque brachytherapy
54 primary target
55 primary treatment
56 proton beam
57 proton therapy
58 questions
59 radiation
60 radiation oncologists
61 radiation therapy techniques
62 recommendations
63 recurrent tumors
64 results
65 retina
66 retrospective study
67 significant efforts
68 sites
69 study
70 system sites
71 target
72 technique
73 therapy
74 therapy techniques
75 threshold doses
76 tolerance
77 treatment
78 treatment of tumors
79 treatment planning
80 tumors
81 schema:name Eye Tumors
82 schema:pagination 95-99
83 schema:productId N20f29c6585034ed7a634d6cf56530b13
84 Nf98aff1369f14256bb9d8d7f874b7aca
85 schema:publisher N8df49ac378ca42dbaf9686ab55253d14
86 schema:sameAs https://app.dimensions.ai/details/publication/pub.1048020567
87 https://doi.org/10.1007/174_2010_107
88 schema:sdDatePublished 2022-12-01T06:47
89 schema:sdLicense https://scigraph.springernature.com/explorer/license/
90 schema:sdPublisher N81c46d9f2f4d497bb5e66a5aa8ffcec5
91 schema:url https://doi.org/10.1007/174_2010_107
92 sgo:license sg:explorer/license/
93 sgo:sdDataset chapters
94 rdf:type schema:Chapter
95 N0db6cb187c4a412e842bd2994c9e512f schema:familyName Nieder
96 schema:givenName Carsten
97 rdf:type schema:Person
98 N20f29c6585034ed7a634d6cf56530b13 schema:name doi
99 schema:value 10.1007/174_2010_107
100 rdf:type schema:PropertyValue
101 N59a14d89d2cd42319be942bb5e8c9cd0 schema:isbn 978-3-642-12467-9
102 978-3-642-12468-6
103 schema:name Re-irradiation: New Frontiers
104 rdf:type schema:Book
105 N695f949dbd55485eb72ebd007d62f100 rdf:first Nf28229ce86da4ab89c6f9f408946c42a
106 rdf:rest rdf:nil
107 N81c46d9f2f4d497bb5e66a5aa8ffcec5 schema:name Springer Nature - SN SciGraph project
108 rdf:type schema:Organization
109 N8df49ac378ca42dbaf9686ab55253d14 schema:name Springer Nature
110 rdf:type schema:Organisation
111 Nae3a8d5af47f4b36bdcdd3a91304d20b rdf:first N0db6cb187c4a412e842bd2994c9e512f
112 rdf:rest N695f949dbd55485eb72ebd007d62f100
113 Ned9ebb4a63a54eab88d48b94ebbc7dc0 rdf:first sg:person.0637022555.52
114 rdf:rest rdf:nil
115 Nf28229ce86da4ab89c6f9f408946c42a schema:familyName Langendijk
116 schema:givenName Johannes A.
117 rdf:type schema:Person
118 Nf98aff1369f14256bb9d8d7f874b7aca schema:name dimensions_id
119 schema:value pub.1048020567
120 rdf:type schema:PropertyValue
121 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
122 schema:name Medical and Health Sciences
123 rdf:type schema:DefinedTerm
124 anzsrc-for:1113 schema:inDefinedTermSet anzsrc-for:
125 schema:name Ophthalmology and Optometry
126 rdf:type schema:DefinedTerm
127 sg:person.0637022555.52 schema:affiliation grid-institutes:grid.214458.e
128 schema:familyName Munzenrider
129 schema:givenName John E.
130 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0637022555.52
131 rdf:type schema:Person
132 grid-institutes:grid.214458.e schema:alternateName Department of Radiation Oncology, Cox 802, Massachusetts General Hospital, 02114, Boston, MA, USA
133 schema:name Department of Radiation Oncology, Cox 802, Massachusetts General Hospital, 02114, Boston, MA, USA
134 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...